Clinical Trial Update: Randomized Trial to Evaluate the Effectiveness of X-22 as a Smoking Cessation Aid [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating X-22 as a smoking cessation aid has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Drugs mentioned

• X-22

Snippet

Sponsor: 22nd Century Limited, LLC | Conditions: Smoking Cessation | Phase 2 | Status: COMPLETED | Results posted: 2021-11-19